Case report: Moderate therapeutic response to Bevacizumab in late-onset Labrune syndrome

Overview of attention for article published in Frontiers in Neurology, September 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 10,265 followers.

New Research: Case report: Moderate therapeutic response to Bevacizumab in late-onset Labrune syndrome: Labrune syndrome (LS) is caused by SNORD118 gene mutations with a particular neuroimaging of white matter disease, intracranial… https://t.co/Dnw50uHxQD

27 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.